Roadmap to resuming care for liver diseases after coronavirus disease-2019

Devika Kapuria1, Steven Bollipo2,3, Atoosa Rabiee4

  • 1Division of Gastroenterology and Hepatology, University of New Mexico, Albuquerque, New Mexico, USA.

Insights

Patients with chronic liver disease face risks from COVID-19 disruptions. This guide offers a roadmap for safely resuming liver care, focusing on outpatient services, transplantation, cancer care, and endoscopy.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted healthcare, particularly for vulnerable chronic liver disease patients.
  • Chronic liver disease is an independent risk factor for COVID-19 related hospital mortality.
  • Interim management changes, including telehealth and postponed procedures, were recommended for liver disease patients.

Purpose of the Study:

  • To provide a roadmap for the safe resumption of clinical operations for patients with chronic liver disease.
  • To minimize exposure risks for patients and healthcare professionals during the pandemic.
  • To address specific care areas including outpatient services, liver transplantation, liver cancer, and endoscopy.

Main Methods:

  • Review and synthesis of recommendations from national and international societies.
  • Development of a phased approach for resuming clinical services.
  • Emphasis on risk mitigation strategies for patient and provider safety.

Main Results:

  • Concern exists regarding increased morbidity from delayed diagnosis and treatment.
  • A potential delayed surge in decompensated liver disease hospitalizations is anticipated post-pandemic.
  • The roadmap outlines strategies for safe outpatient care, transplantation, cancer management, and endoscopy.

Conclusions:

  • Safe resumption of liver care requires a comprehensive, phased plan.
  • Proactive planning is essential to mitigate risks associated with pandemic-related healthcare disruptions.
  • Prioritizing patient and healthcare professional safety is paramount during service resumption.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
206
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
279
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
139
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
107
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K